Pharmacist‑Led Oncology Solutions

Partnering with physicians and health systems to deliver safe, effective, patient‑centered oral oncolytic care.

We implement evidence‑based medication management programs that improve adherence, enhance safety monitoring, streamline access, and elevate outcomes.

Oral Oncolytic Programs Medically Integrated Dispensing Collaborative Practice Agreements Adherence & Toxicity Monitoring

Services

Evidence‑based offerings for physicians, oncology clinics, and hospital systems.

4–6 weeks

OC Program QuickStart

Design and launch a pharmacist‑led oral oncolytic management program.

  • Gap assessment vs HOPA practice standards
  • Workflows for prescribing, education, dispensing, follow‑up
  • Templates: counseling, toxicity checklists, adherence tools
6–12 weeks

Medically Integrated Dispensing (MID)

Stand up or optimize a medically integrated dispensing model aligned with ASCO/NCODA standards.

  • Prior auth & financial navigation workflow
  • Refill synchronization & possession tracking
  • Closed‑loop EMR documentation & reporting
Monthly

CPA & Monitoring Program

Implement a collaborative practice agreement and pharmacist‑run monitoring.

  • CPA for refills, dose rounding/adjustments, lab orders
  • 7–14 day start follow‑ups; PROs before each refill
  • Quality dashboard: adherence, AEs, turnaround time

Approach

Build from standards, tailor to your clinic. We combine clinic‑embedded workflows with pharmacist autonomy.

How we work

  • Assess: Map current state; identify gaps in prescribing, education, dispensing, follow‑up.
  • Design: SOPs, EHR templates, CPA language, monitoring schedules, documentation.
  • Operationalize: Train staff; pilot with 10–20 patients; iterate based on AE/adherence signals.

Expected outcomes

  • Faster prescription turnaround via CPA‑driven workflows
  • Higher adherence & AE capture with 2‑ and 4‑week touchpoints
  • Reduced financial barriers through integrated benefits navigation

Process & Packages

Structured, outcomes‑oriented engagement models designed to align with physician practices, hospital systems, and RFP expectations.

Pilot Program

A time‑boxed pilot to demonstrate feasibility and generate early outcomes data.

  • Baseline gap assessment vs. HOPA standards
  • Implement pharmacist counseling & monitoring workflows
  • Collect initial metrics (adherence, AE reporting, turnaround)
  • Weekly stakeholder updates with preliminary dashboard

Full Implementation

A clinic‑ or system‑wide rollout designed to integrate sustainable pharmacist‑led oral oncolytic services.

  • Collaborative Practice Agreement (CPA) setup and protocols
  • Integration with EMR and specialty pharmacy workflows
  • Financial navigation and access services alignment
  • Comprehensive staff training and change management
  • Quarterly outcomes reporting mapped to quality benchmarks

Fractional Advisory

Ongoing program oversight and outcomes optimization for established services.

  • Monthly data review and continuous quality improvement (CQI)
  • Guideline updates integrated into workflows
  • Quarterly staff refreshers and stakeholder briefings
  • Strategic input for grant applications and RFP responses

About

Led by a PharmD consultant with experience designing cross‑functional programs in regulated settings. We translate HOPA standards and ASCO/NCODA MID guidance into operational reality for your setting.

Focus

  • Standardized patient education & counseling
  • Adherence & toxicity monitoring cadence
  • Closed‑loop refill & lab review process

Domains

  • Oral Oncolytics
  • CPA Implementation
  • Quality & Safety

Let’s talk

Share your site type (clinic/hospital/private practice), EMR, and goals (adherence, access, turnaround time). We’ll reply with a short proposal and options.

Thank you! Your message has been sent.

Response time

We respond within one business day. Based in US Central.

Preferred projects

  • Clear ownership & measurable outcomes
  • Weekly momentum and decision access
  • Willingness to iterate quickly